Nasdaq

Roche launches cobas prime Pre-analytical System, a first-of-its-kind solution designed to automate all common manual steps in molecular diagnostics laboratories

PLEASANTON, Calif., July 30, 2020 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® prime Pre-analytical System to improve efficiency in molecular diagnostics ...
Nasdaq

Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
FierceBiotech

Roche launches more compact cobas 5800 analyzer for smaller European diagnostic labs

Roche launched a relatively more compact addition to its mainstay cobas molecular diagnostic lineup with instruments that aim to bring automated testing to laboratories of all sizes. Roche is ...
Fierce Healthcare

Roche Receives FDA Approval for cobas p 630 Pre-analytical Solution for Automated Molecular Testing Platform

PLEASANTON, Calif., March 30, 2012 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the FDA approval of a new pre-analytical instrument that provides an integrated primary tube ...
News Medical

Roche Diagnostics introduces new molecular laboratory instrument in the UK

Roche Diagnostics has launched its new molecular laboratory instrument, the cobas ® 5800 System, in the UK. Through improved automation the new system can help raise testing volumes, improve ...
Morningstar

Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers

HERLEV, Denmark , May 8, 2025 /PRNewswire/ -- Nordic Bioscience announces that its PRO-C3 test is launched by Roche Diagnostics on their cobas analysers. The Roche Elecsys® PRO-C3, used with the ADAPT ...
The American Journal of Managed Care

Roche Molecular Diagnostic's cobas HPV Test Approved by the FDA

A test that can detect the DNA of the human papilloma virus (HPV), to confirm the need for cervical cancer screening in women 25 years and older, has gained the FDA’s support as a primary screening ...
FiercePharma

FDA approves new streamlined workflow option for Roche's cobas HPV Test

New process allows labs to use same Pap test vial instead of transferring sample to new vial, thus simplifying workflow INDIANAPOLIS, June 26, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) ...
FiercePharma

Roche Submits Total Vitamin D Assay to FDA for Clearance on Cobas Immunoassay and Elecsys Analyzers

INDIANAPOLIS, Dec. 5, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated ...
MedCity News

Roche’s $1.8B GenMark deal brings a key testing capability for Covid-19 and beyond

Roche is adding to its diagnostic capabilities through a deal to acquire GenMark Diagnostics, a molecular diagnostics company whose technology tests for multiple pathogens—including the novel ...
FierceBiotech

FDA approves new streamlined workflow option for Roche's cobas HPV Test

New process allows labs to use same Pap test vial instead of transferring sample to new vial, thus simplifying workflow INDIANAPOLIS, June 26, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) ...